Rosa Drago‐Ferrante

739 total citations
21 papers, 589 citations indexed

About

Rosa Drago‐Ferrante is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Rosa Drago‐Ferrante has authored 21 papers receiving a total of 589 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 9 papers in Cancer Research and 8 papers in Oncology. Recurrent topics in Rosa Drago‐Ferrante's work include MicroRNA in disease regulation (6 papers), Cancer Cells and Metastasis (5 papers) and Cancer-related Molecular Pathways (5 papers). Rosa Drago‐Ferrante is often cited by papers focused on MicroRNA in disease regulation (6 papers), Cancer Cells and Metastasis (5 papers) and Cancer-related Molecular Pathways (5 papers). Rosa Drago‐Ferrante collaborates with scholars based in Italy, United States and Malta. Rosa Drago‐Ferrante's co-authors include Riccardo Di Fiore, Renza Vento, Daniela Carlisi, Anna De Blasio, Giovanni Tesoriere, Christian Scerri, Antonio Giordano, Francesca Pentimalli, Michela Giuliano and Antonella D’Anneo and has published in prestigious journals such as International Journal of Molecular Sciences, Journal of Cellular Physiology and Bone.

In The Last Decade

Rosa Drago‐Ferrante

20 papers receiving 578 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rosa Drago‐Ferrante Italy 13 414 279 182 75 32 21 589
Vaidotas Stankevičius Lithuania 13 400 1.0× 249 0.9× 196 1.1× 104 1.4× 36 1.1× 22 632
Christine Wittig Germany 7 396 1.0× 163 0.6× 164 0.9× 91 1.2× 36 1.1× 8 584
Henri Wichmann Germany 16 375 0.9× 202 0.7× 107 0.6× 91 1.2× 18 0.6× 20 561
Rongfu Tu China 11 533 1.3× 228 0.8× 132 0.7× 53 0.7× 13 0.4× 22 652
Joon Hee Kang South Korea 15 349 0.8× 297 1.1× 77 0.4× 78 1.0× 26 0.8× 27 577
Sumit Das India 5 283 0.7× 123 0.4× 175 1.0× 59 0.8× 24 0.8× 6 468
Nathalie Bauer Germany 14 432 1.0× 329 1.2× 246 1.4× 39 0.5× 27 0.8× 20 690
Olga Surova Sweden 11 404 1.0× 163 0.6× 118 0.6× 43 0.6× 15 0.5× 17 564
Amirabbas Kakavand Iran 11 367 0.9× 239 0.9× 126 0.7× 77 1.0× 25 0.8× 14 530
Najah Albadari United States 7 269 0.6× 209 0.7× 119 0.7× 47 0.6× 27 0.8× 16 476

Countries citing papers authored by Rosa Drago‐Ferrante

Since Specialization
Citations

This map shows the geographic impact of Rosa Drago‐Ferrante's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rosa Drago‐Ferrante with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rosa Drago‐Ferrante more than expected).

Fields of papers citing papers by Rosa Drago‐Ferrante

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rosa Drago‐Ferrante. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rosa Drago‐Ferrante. The network helps show where Rosa Drago‐Ferrante may publish in the future.

Co-authorship network of co-authors of Rosa Drago‐Ferrante

This figure shows the co-authorship network connecting the top 25 collaborators of Rosa Drago‐Ferrante. A scholar is included among the top collaborators of Rosa Drago‐Ferrante based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rosa Drago‐Ferrante. Rosa Drago‐Ferrante is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fiore, Riccardo Di, et al.. (2024). Sarcopenia in gynaecological cancers. European Journal of Surgical Oncology. 51(4). 108403–108403.
2.
Fiore, Riccardo Di, et al.. (2024). The role of microRNA-9 in ovarian and cervical cancers: An updated overview. European Journal of Surgical Oncology. 51(4). 108546–108546. 2 indexed citations
3.
Fiore, Riccardo Di, Rosa Drago‐Ferrante, Yashwanth Subbannayya, et al.. (2023). The Role of FBXW7 in Gynecologic Malignancies. Cells. 12(10). 1415–1415. 10 indexed citations
4.
Drago‐Ferrante, Rosa, Riccardo Di Fiore, Fathi Karouia, et al.. (2022). Extraterrestrial Gynecology: Could Spaceflight Increase the Risk of Developing Cancer in Female Astronauts? An Updated Review. International Journal of Molecular Sciences. 23(13). 7465–7465. 12 indexed citations
5.
Fiore, Riccardo Di, Rosa Drago‐Ferrante, Yashwanth Subbannayya, et al.. (2022). Cancer Stem Cells and Their Possible Implications in Cervical Cancer: A Short Review. International Journal of Molecular Sciences. 23(9). 5167–5167. 40 indexed citations
6.
Fiore, Riccardo Di, Rosa Drago‐Ferrante, Ana Félix, et al.. (2021). LncRNA MORT (ZNF667-AS1) in Cancer—Is There a Possible Role in Gynecological Malignancies?. International Journal of Molecular Sciences. 22(15). 7829–7829. 12 indexed citations
7.
Blasio, Anna De, Riccardo Di Fiore, Rosa Drago‐Ferrante, et al.. (2019). A loop involving NRF2, miR‐29b‐1‐5p and AKT, regulates cell fate of MDA‐MB‐231 triple‐negative breast cancer cells. Journal of Cellular Physiology. 235(2). 629–637. 40 indexed citations
8.
Blasio, Anna De, Rosa Drago‐Ferrante, Christian Saliba, et al.. (2019). Loss of MCL1 function sensitizes the MDA‐MB‐231 breast cancer cells to rh‐TRAIL by increasing DR4 levels. Journal of Cellular Physiology. 234(10). 18432–18447. 11 indexed citations
9.
Carlisi, Daniela, Anna De Blasio, Rosa Drago‐Ferrante, et al.. (2017). Parthenolide prevents resistance of MDA-MB231 cells to doxorubicin and mitoxantrone: the role of Nrf2. Cell Death Discovery. 3(1). 17078–17078. 53 indexed citations
10.
Drago‐Ferrante, Rosa, Francesca Pentimalli, Daniela Carlisi, et al.. (2017). Suppressive role exerted by microRNA-29b-1-5p in triple negative breast cancer through SPIN1 regulation. Oncotarget. 8(17). 28939–28958. 52 indexed citations
11.
Blasio, Anna De, Riccardo Di Fiore, M. Morreale, et al.. (2016). Unusual roles of caspase-8 in triple-negative breast cancer cell line MDA-MB-231. International Journal of Oncology. 48(6). 2339–2348. 24 indexed citations
12.
Carlisi, Daniela, Riccardo Di Fiore, Christian Scerri, et al.. (2016). Parthenolide and DMAPT exert cytotoxic effects on breast cancer stem-like cells by inducing oxidative stress, mitochondrial dysfunction and necrosis. Cell Death and Disease. 7(4). e2194–e2194. 75 indexed citations
13.
Fiore, Riccardo Di, Rosa Drago‐Ferrante, Francesca Pentimalli, et al.. (2015). Let-7d miRNA Shows Both Antioncogenic and Oncogenic Functions in Osteosarcoma-Derived 3AB-OS Cancer Stem Cells. Journal of Cellular Physiology. 231(8). 1832–1841. 39 indexed citations
14.
Fiore, Riccardo Di, Rosa Drago‐Ferrante, Francesca Pentimalli, et al.. (2014). MicroRNA-29b-1 impairs in vitro cell proliferation, self-renewal and chemoresistance of human osteosarcoma 3AB-OS cancer stem cells. International Journal of Oncology. 45(5). 2013–2023. 55 indexed citations
15.
Fiore, Riccardo Di, Michela Marcatti, Rosa Drago‐Ferrante, et al.. (2014). Mutant p53 gain of function can be at the root of dedifferentiation of human osteosarcoma MG63 cells into 3AB-OS cancer stem cells. Bone. 60. 198–212. 37 indexed citations
16.
Fiore, Riccardo Di, Rosa Drago‐Ferrante, Antonella D’Anneo, et al.. (2013). In human retinoblastoma Y79 cells okadaic acid–parthenolide co-treatment induces synergistic apoptotic effects, with PTEN as a key player. Cancer Biology & Therapy. 14(10). 922–931. 16 indexed citations
17.
Fiore, Riccardo Di, Rosa Drago‐Ferrante, Antonella D’Anneo, et al.. (2013). Differentiation of human osteosarcoma 3AB-OS stem-like cells in derivatives of the three primary germ layers as a useful <i>in vitro</i> model to develop several purposes. Nova Science Publishers (Nova Science Publishers, Inc.). 3(3). 188–201. 5 indexed citations
18.
Fiore, Riccardo Di, Daniele Fanale, Rosa Drago‐Ferrante, et al.. (2012). Genetic and molecular characterization of the human Osteosarcoma 3AB‐OS cancer stem cell line: A possible model for studying osteosarcoma origin and stemness. Journal of Cellular Physiology. 228(6). 1189–1201. 42 indexed citations
19.
Fiore, Riccardo Di, Annalisa Guercio, Roberto Puleio, et al.. (2012). Modeling human osteosarcoma in mice through 3AB‐OS cancer stem cell xenografts. Journal of Cellular Biochemistry. 113(11). 3380–3392. 34 indexed citations
20.
Drago‐Ferrante, Rosa. (1992). Low doses of paclitaxel potently induce apoptosis in human retinoblastoma Y79 cells by up-regulating E2F1. International Journal of Oncology. 33(4). 677–87. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Vaidotas Stankevičius Breakdown of academic impact, for papers by Christine Wittig Breakdown of academic impact, for papers by Henri Wichmann Breakdown of academic impact, for papers by Rongfu Tu Breakdown of academic impact, for papers by Joon Hee Kang Breakdown of academic impact, for papers by Sumit Das Breakdown of academic impact, for papers by Nathalie Bauer Breakdown of academic impact, for papers by Olga Surova Breakdown of academic impact, for papers by Amirabbas Kakavand Breakdown of academic impact, for papers by Najah Albadari
Rankless by CCL
2026